1. Home
  2. FNKO vs MIST Comparison

FNKO vs MIST Comparison

Compare FNKO & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Funko Inc.

FNKO

Funko Inc.

HOLD

Current Price

$3.09

Market Cap

170.8M

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$2.59

Market Cap

163.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNKO
MIST
Founded
2017
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.8M
163.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
FNKO
MIST
Price
$3.09
$2.59
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$7.13
$6.33
AVG Volume (30 Days)
894.4K
3.8M
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$928,842,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$0.63
52 Week High
$14.65
$2.77

Technical Indicators

Market Signals
Indicator
FNKO
MIST
Relative Strength Index (RSI) 47.88 62.71
Support Level $2.97 $2.50
Resistance Level $3.15 $2.73
Average True Range (ATR) 0.15 0.16
MACD -0.00 0.00
Stochastic Oscillator 62.16 61.76

Price Performance

Historical Comparison
FNKO
MIST

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: